Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

LICC: L-BLP25 in Patients with Colorectal Carcinoma after curative resection of hepatic metastases – a randomized, placebo-controlled, multicenter, multinational, double blinded phase II trial.

Next Previous
X
Search
Trial Profile

LICC: L-BLP25 in Patients with Colorectal Carcinoma after curative resection of hepatic metastases – a randomized, placebo-controlled, multicenter, multinational, double blinded phase II trial.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 07 Mar 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cyclophosphamide (Primary) ; Tecemotide (Primary)
  • Indications Adenocarcinoma; Colorectal cancer; Liver metastases
  • Focus Therapeutic Use
  • Acronyms LICC

    • Most Recent Events

    • 15 Apr 2022 Results Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3) assessing survival after secondary liver resection in metastatic colorectal cancerpublished in the International Journal of Cancer
    • 04 Jun 2019 Results of a comparative analysis assessing survival after secondary liver resection in metastatic colorectal cancer in LICC, FIRE-3 and CELIM, presented at the 55th Annual Meeting of the American Society of Clinical Oncology
    • 04 Jun 2019 Primary endpoint (Recurrence-free survival (RFS) time and 3 year overall survival (OS) time) has not been met, according to the results presented at the 55th Annual Meeting of the American Society of Clinical Oncology

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top